Swedbank AB:企業の戦略・SWOT・財務情報

◆英語タイトル:Swedbank AB - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11906
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Swedbank AB – Strategy, SWOT and Corporate Finance Report
Summary

Swedbank AB – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Swedbank AB (Swedbank) offers individual and corporate banking solutions. Individual banking comprises life and non-life insurance, pensions, financial planning, asset management, investment advisory, and ownership and generation shift services. Corporate banking contains fund management, analysis and insights, leasing and factoring, marine and export finance, and acquisition and project finance. It also offers cash management, transaction banking, trade financing, loans and syndications, debt capital market, corporate finance, fixed income trading, structure products, currency trading, and equity sales and equity capital markets. Swedbank offers products and services to individual and corporate clients through a network of branch offices and online portals. It operates in the regions of Europe, North America, Asia, and Africa. Swedbank is headquartered in Stockholm, Sweden.

Scope

- Detailed information on Swedbank AB required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Swedbank AB in the form of a SWOT analysis
- An in-depth view of the business model of Swedbank AB including a breakdown and examination of key business segments
- Intelligence on Swedbank AB’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Swedbank AB, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Swedbank AB and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Swedbank AB as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Swedbank AB’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Swedbank AB: Company Overview 9
Swedbank AB: Overview and Key Facts 9
Swedbank AB: Overview 9
Swedbank AB: Key Facts 9
Swedbank AB: Key Employees 11
Swedbank AB: Key Employee Biographies 13
Swedbank AB: Major Products and Services 15
Swedbank AB: Company History 17
Swedbank AB: Management Statement 20
Swedbank AB: Locations and Subsidiaries 23
Swedbank AB: Key Competitors 25
Swedbank AB: Company Analysis 26
Swedbank AB: Business Description 26
Swedbank AB: SWOT Analysis 27
Swedbank AB: SWOT Overview 27
Swedbank AB: Strengths 27
Swedbank AB: Weaknesses 28
Swedbank AB: Opportunities 28
Swedbank AB: Threats 28
Swedbank AB: Corporate Financial Deals Activity 30
Swedbank AB: Financial Deals Overview 30
Swedbank AB: Targets and Partners 32
Swedbank AB: Top Deals 2014 – 2018YTD* 33
Swedbank AB: Advisors 34
Swedbank AB: Top Financial Advisors 34
Swedbank AB: Mergers and Acquisitions 36
Swedbank AB: Corporate Venturing 37
Swedbank AB: Capital Raising 38
Swedbank AB: Divestments 39
Swedbank AB: Recent Developments 40
Swedbank AB: News and Events Summary 40
Swedbank AB: Business Reorganization 42
Swedbank AB: Contracts 43
Swedbank AB: Corporate Governance 43
Swedbank AB: Financial Deals 44
Swedbank AB: Financial Performance 45
Swedbank AB: Red Flags/DistressSignals 45
Swedbank AB: Strategy and Operations 45
Appendix 47
Contact Us 47
Methodology 47
About MarketLine 48

List of Tables
Table 1: Swedbank AB: Key Facts
Table 2: Swedbank AB: Key Employees
Table 3: Swedbank AB: Company History
Table 4: Swedbank AB: Locations and Subsidiaries
Table 5: Swedbank AB: Key Competitors
Table 6: Swedbank AB: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Swedbank AB: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Swedbank AB: Targets and Partners
Table 9: Swedbank AB: Top Deals 2014 - 2018YTD*
Table 10: Swedbank AB: Financial Advisor Ranking by Value (US$m)
Table 11: Swedbank AB: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Swedbank AB: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Swedbank AB: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 14: Swedbank AB: Corporate Venturing by Geography (2014 - YTD*2018)
Table 15: Swedbank AB: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 16: Swedbank AB: Capital Raising by Deal Type (2014 - YTD*2018)
Table 17: Swedbank AB: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: Swedbank AB: Divestments by Geography (2014 - YTD*2018)
Table 19: Swedbank AB: News and Events Summary
Table 20: Swedbank AB: Business Reorganization
Table 21: Swedbank AB: Contracts
Table 22: Swedbank AB: Corporate Governance
Table 23: Swedbank AB: Financial Deals
Table 24: Swedbank AB: Financial Performance
Table 25: Swedbank AB: Red Flags/DistressSignals
Table 26: Swedbank AB: Strategy and Operations

List of Figures
Figure 1: Swedbank AB: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Swedbank AB: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Swedbank AB: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Swedbank AB: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Swedbank AB: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 6: Swedbank AB: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 7: Swedbank AB: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Swedbank AB: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 9: Swedbank AB: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Swedbank AB: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Swedbank AB:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eesti Energia AS:企業の戦略・SWOT・財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The National Gas Company of Trinidad and Tobago Ltd:企業の戦略的SWOT分析
    The National Gas Company of Trinidad and Tobago Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • Epicor Software Corp:企業の戦略的SWOT分析
    Epicor Software Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • ClearPoint Neuro Inc (CLPT):企業の財務・戦略的SWOT分析
    Summary ClearPoint Neuro Inc (ClearPoint) is a medical equipment company. It develops and commercializes platforms for performing invasive surgical procedures. Its products include ClearPoint system a surgical platform, that enables delivery of therapies treat a neurological diseases and disorders b …
  • Recordati SpA (REC):製薬・医療:M&Aディール及び事業提携情報
    Summary Recordati SpA (Recordati), a subsidiary of Fimei SpA is a pharmaceutical company that researches, develops, manufactures and markets pharmaceuticals. The company offers pharmaceuticals for cardiovascular diseases, dermatology, central nervous system disorders, musculo-skeletal disorders and …
  • Portland General Electric Company:発電所・企業SWOT分析
    Portland General Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Allen & Overy LLP:企業の戦略的SWOT分析
    Allen & Overy LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Ewopharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Ewopharma AG (Ewopharma) is a pharmaceutical company that provides registration and marketing of pharmaceuticals and consumer health products. The company provides services such as market evaluation, marketing services, regulatory affairs, licensing, pharmacovigilance, and others. It offers …
  • Myer Holdings Ltd:企業の戦略・SWOT・財務分析
    Myer Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Myer Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Carmell Therapeutics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio include adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for total j …
  • Amil Assistencia Medica Internacional S/A:企業の戦略・SWOT・財務情報
    Amil Assistencia Medica Internacional S/A - Strategy, SWOT and Corporate Finance Report Summary Amil Assistencia Medica Internacional S/A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • International Business Machines Corporation:企業のM&A・事業提携・投資動向
    International Business Machines Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's International Business Machines Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Program for Appropriate Technology in Health-製薬・医療分野:企業M&A・提携分析
    Summary Program for Appropriate Technology in Health (PATH) is a healthcare organization that offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. The organization offers HIV and AIDS, influenza, malaria and tuberculosis care services. It develo …
  • Republic Services, Inc.:企業の戦略・SWOT・財務情報
    Republic Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Republic Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Quanterix Corp (QTRX):医療機器:M&Aディール及び事業提携情報
    Summary Quanterix Corp (Quanterix) is a life sciences company that develops and markets ultra-sensitive digital immunoassay platform that improves precision health for life sciences research and diagnostics. The company develops platform based on its proprietary digital single molecule array, Simoa …
  • AliveCor Inc:医療機器:M&Aディール及び事業提携情報
    Summary AliveCor Inc (AliveCor) is a heart rate measuring technology provider. The company offers kardia mobile and kardia application. It provides medical-grade EKG in just thirty seconds. AliveCor’s kardia offers easy to use, affordable, portable and trusted. The company track data over time and m …
  • Pacgen Life Science Corp (PBS)-製薬・医療分野:企業M&A・提携分析
    Summary Pacgen Life Science Corp (Pacgen), formerly Pacgen Biopharmaceuticals Corp is a life science technology company that develops and commercializes biomedical products and services. The company offers development of novel therapeutic drug candidates. Its products include amino-acid antimicrobia …
  • UnitedHealth Group Incorporated:企業の戦略・SWOT・財務分析
    UnitedHealth Group Incorporated - Strategy, SWOT and Corporate Finance Report Summary UnitedHealth Group Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Hikma Pharmaceuticals PLC:企業のM&A・事業提携・投資動向
    Hikma Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hikma Pharmaceuticals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Urenco Ltd:企業の戦略・SWOT・財務分析
    Urenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Urenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆